By Professor Claire Vajdic

Preprints

MacManus MP; Seymour JF; Tsang H; Fisher R; Keane C; Sabdia MB; Law SC; Gunawardana J; Nath K; Kazakoff SH; Marques-Piubelli ML; Duenas DE; Green MR; Roos D; O’Brien P; McCann A; Tsang R; Davis S; Christie D; Cheah C; Amanuel B; Cochrane T; Butler J; Johnston A; Shanavas M; Li L; Vajdic C; Kridel R; Shelton V; Hershenfield S; Baetz T; Lebrun D; Johnson N; Brodtkorb M; Ludvigsen M; d’Amore F; Thompson ER; Blombery P; Gandhi MK; Tobin JWD, 2024, Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in early-stage follicular lymphoma: TROG99.03, http://dx.doi.org/10.1101/2024.08.09.24311704

Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson S-A, 2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520

Keay L; Ren K; Nguyen H; Vajdic C; Odutola M; Gyawali R; Toomey M; Peters R; Ee N; Dillon L; Hackett M; Ah Tong B; D'Esposito F; Faulmann D; Burton M; Ramke J; Jalbert I, 2022, Risk factors common to leading eye health conditions and major non-communicable diseases: a rapid review and commentary, http://dx.doi.org/10.12688/f1000research.123815.1

Hong S; Daniels B; Leeuwen MT; Pearson S-A; Vajdic CM, 2021, Incidence And Risk Factors of Hypertension Therapy In Australian Cancer Patients Treated With Vascular Signalling Pathway Inhibitors, http://dx.doi.org/10.21203/rs.3.rs-1006781/v1

Rosales B; Hedley J; De La Mata N; Vajdic CM; Kelly P; Wyburn K; Webster AC, 2020, Safety and Biovigilance in Organ Donation (SAFEBOD): Protocol for a Population-Based Cohort Study (Preprint), http://dx.doi.org/10.2196/preprints.18282

Back to profile page